Live Case Example: Cer lated Your client is the CEO of a biotech startup that has been working from home and watching a new virus called “BUD-19" go more viral than Gangnam Style, Despacito, and the Baby Shark Dance combined. He is thinking of having his company pivot to enter the race for a cure and er RCS UAL) Mek) chance of being the first to market. If they fail, they will likely run out of funding. Should his eels As oneLive Case Example: een ected You: Just so | understand, our client wants to eA M o) Comme alee RTM UME Lei} for a vaccine for a virus called BUD-19? They Cet eR Aeetce een RAUCNaCT| Pecwakea Ramtec Une Ula em la reel reieLive Case Example: The BUD-19 Pivot You: What does success look like for the client? Interviewer: They want to see a profit from this. Por RoR eel BR ead Nelo lee 0Live Case Example: Opening - Clarifying Questions Scene ea Pee A eRe ea ey vaccine that many people are putting a prize money to find the tear SS a Ra ka Interviewer: Yes, countries around the world have put together a Sr eae ea haa pees Sea Cc ne Ce rk iu Interviewer: The FDA requires that all drugs in order to reach Ge ee ieee a Cee ree eM eta healBUD-19 = virus with ne Tee cal 2008 for first FDA vaccine 10% of 1st to market FDA = 3 stage of approvalStep 3 : Add Buckets That Influence Your Main BucketStep 4 : Specialize Your Buckets As Specific as Possible Wil the cent be profitable? | | _lsthe-lentin situation to | | Isthere market demand fora | |Will the competitors beat us to support the R&D of vaccine? vaccine? market?Step 5 : Specialize Your Sub-BucketsAs an interviewer which one is better? a SS Customer Company Competitors Product Isthe cientin situation to | | Is there market demand fora | [Willthe competitors beat us to il the client be profitable? i support the R&D of vaccine? vaccine? market?BUD-19 = virus with no $2008 for first FDA vaccine 10% of 1st to market FDA = 3 stage of approval Enter/No Ente Obj - Profit You can shorthand and voiceover your notes Piette eyLive Case Example: Analysis Interviewer: Where would you like to start? You: | want to look at the expected profits since that is what we care about the most. I'd like to start first by looking at the cost side. Do we have any data on the expected costs?The Analysis - Exhibits Estimated Cost ($M) for BUD-19 Vaccine of Vaccine PStep 3: Give “So What” - What is the insight? Cost to Enter som soon aoe con Son paning Fi) % oF Entering 100% som pausing 2) (passing F) = 20% ( x Expected Cont seam seme sas Gases oStep 2: What Does the Data/Info Say? Total Revenue $2008 From Opening. % of Getting Revenue o* From Previous Exhibit Expected Revenue Able To Launch $2008 * 5% = $108 Calculation % of Being First To Market, Expected Revenue 10% $108 * 10% = $18 From Opening Calculation We DoStep 3: What’s the “So What?” Total Revenue $2008 From Opening % of Getting Revenue * ted Revenue If Able To Launch % of Being First To Market Expected Revenue Calculation We DoNow you understand how the analysis works Ts the client in situation to =e caiman lease cana | [comets] [Pecans] [te rar we cent enna escort + sre as Shes * eT Sa